Again, when HCC patients were compared with LC patients, the AUC for thioredoxin was also larger than that for AFP (0.805, 0.769–0.842 vs. 0.704, 0.661–0.763, P = 0.002). The gene discussed is TXN; the disease is hepatocellular carcinoma.